PubRank

Mengfeng Li

Author PubWeight™ 70.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008 3.04
2 The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009 2.52
3 TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets. J Clin Invest 2012 2.10
4 Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells. J Pathol 2010 1.82
5 MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. J Clin Invest 2013 1.76
6 MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. J Clin Invest 2011 1.60
7 Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 2009 1.59
8 Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 2010 1.57
9 Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol 2009 1.54
10 Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clin Cancer Res 2008 1.40
11 Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Clin Cancer Res 2004 1.39
12 Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin Cancer Res 2011 1.38
13 Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res 2012 1.33
14 miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res 2012 1.29
15 miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res 2013 1.27
16 Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int J Cancer 2011 1.24
17 miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 2011 1.20
18 MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. FEBS Lett 2012 1.20
19 miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops. Cell Res 2012 1.17
20 Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells. Gastroenterology 2012 1.15
21 SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway. Br J Pharmacol 2010 1.14
22 Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a. PLoS One 2012 1.09
23 Cytotoxic norsesquiterpene peroxides from the endophytic fungus Talaromyces flavus isolated from the mangrove plant Sonneratia apetala. J Nat Prod 2011 1.09
24 Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin Cancer Res 2013 1.03
25 EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration. Int J Oncol 2002 1.02
26 MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer. Int J Cancer 2014 1.01
27 Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway. J Pathol 2015 1.00
28 Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2. Nutr Cancer 2006 1.00
29 Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS One 2011 0.99
30 sFlt-1 gene therapy of follicular thyroid carcinoma. Endocrinology 2003 0.99
31 Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer. J Clin Endocrinol Metab 2013 0.99
32 Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer. Mol Endocrinol 2011 0.98
33 Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer 2012 0.96
34 MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One 2013 0.95
35 Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Int J Cancer 2013 0.95
36 Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells. J Clin Invest 2013 0.94
37 Down-regulation of pescadillo inhibits proliferation and tumorigenicity of breast cancer cells. Cancer Sci 2009 0.94
38 Bmi-1 promotes glioma angiogenesis by activating NF-κB signaling. PLoS One 2013 0.92
39 IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-κB. J Pathol 2010 0.92
40 Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond. Cell Biosci 2011 0.91
41 IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection. Cell Microbiol 2014 0.90
42 A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing Akt signaling. Mar Drugs 2012 0.90
43 Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas. Clin Cancer Res 2013 0.89
44 Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair. J Mol Cell Biol 2011 0.89
45 Differentially expressed proteins of pathogenic Penicillium marneffei in yeast and mycelial phases. J Med Microbiol 2007 0.89
46 Nkx2-8 downregulation promotes angiogenesis and activates NF-κB in esophageal cancer. Cancer Res 2013 0.89
47 Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway. J Pathol 2011 0.89
48 Studies on synthesis and structure-activity relationship (SAR) of derivatives of a new natural product from marine fungi as inhibitors of influenza virus neuraminidase. Mar Drugs 2011 0.88
49 Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Clin Cancer Res 2003 0.86
50 Studies on the synthesis of derivatives of marine-derived bostrycin and their structure-activity relationship against tumor cells. Mar Drugs 2012 0.83
51 Beta4 integrin is involved in statin-induced endothelial cell death. Biochem Biophys Res Commun 2004 0.82
52 Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice. Virol J 2011 0.81
53 Approaches to efficient production of recombinant angiogenesis inhibitor rhVEGI-192 and characterization of its structure and antiangiogenic function. Protein Sci 2010 0.81
54 PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells. Int J Cancer 2014 0.81
55 Dual function of RGD-modified VEGI-192 for breast cancer treatment. Bioconjug Chem 2012 0.81
56 Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma. Int J Cancer 2010 0.80
57 RING finger proteins of infectious spleen and kidney necrosis virus (ISKNV) function as ubiquitin ligase enzymes. Virus Res 2006 0.80
58 Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo. Int J Oncol 2003 0.79
59 Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma. Endocrinology 2002 0.78
60 The HMG-CoA reductase pathway, statins and angioprevention. Semin Ophthalmol 2006 0.78
61 Targeting Smad2 and Smad3 by miR-136 suppresses metastasis-associated traits of lung adenocarcinoma cells. Oncol Res 2013 0.77
62 Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates. Virus Genes 2010 0.77
63 CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling. J Clin Invest 2017 0.75